The conference will provide attendees with the opportunity to discuss their training needs within the advanced therapy field and help shape how education and training programmes could look in the future.
This event will deliver a broad overview of the scientific basis of cell and gene therapies and their applications. Alongside this, speakers will provide insight into the scope of therapies currently in development across different diseases with examples from clinical trials in addition to first-hand accounts from a patient perspective on receiving cell and gene therapies.
Matthew Durdy, Chief Business Officer
Overview of the Global and UK Landscape: the challenges and the opportunities
The day is co-charied by Ian Hollingsworth, ATTC Programme Manager for iMATCH
Find out more and how to register here